Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

PCD Logo

ORIGINAL RESEARCH

Comparison of Fecal Occult Blood Tests for Colorectal Cancer Screening in an Alaska Native Population With High Prevalence of Helicobacter pylori Infection, 2008–2012

Among 2,340 participants scheduled for colonoscopy, 1,640 were excluded for the following reasons: no endoscopy or endoscopy was scheduled for the next day, 570; not living in Anchorage, 369; not Alaska Native, 203; not able to stop medications, 166; colorectal cancer symptoms, 98; comprehension, 87; and other, 147. Of the 700 who were eligible for the study, 303 declined to participate. Among the 397 who were enrolled in the study, 93 were excluded for the following reasons: iFOBT/gFOBT incomplete, 29; colonoscopy incomplete, 19; H. pylori test incomplete, 3; and other, 42. This left 304 who completed the study.

Figure. Flow diagram for enrollment in a study of fecal occult blood tests among Alaska Natives, Anchorage, Alaska, 2008–2012. Abbreviations: CRC, colorectal cancer; iFOBT, immunochemical fecal occult blood test; gFOBT, guaiac-based fecal occult blood test; H. pylori, Helicobacter plyori.

Return to article



The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions.

 
For Questions About This Article Contact pcdeditor@cdc.gov
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #